SAN DIEGO--(BUSINESS WIRE)--Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) today announced that Richard W. Pascoe, Somaxon’s president and chief executive officer, will present a company overview at the 12th Annual BIO CEO & Investor Conference at the Waldorf-Astoria Hotel in New York City on Monday, February 8th at 9:30 A.M. Eastern Time.
